comprehensive -WSS

comprehensive

author：knowledge 2025-10-01 04:12:12 - browse：52

Two researchers look at a computer monitor showing a graph and other data — Adobe

Research universities are voicing concerns over some proposed changes to the process for reviewing scientific misconduct allegations, citing worries that new government requirements would hobble their own independent procedures and constitute a huge administrative burden.

Nearly two decades since it last released research misconduct rules, the U.S. Office of Research Integrity (ORI) is ready to update its requirements for ensuring the scientific standards of projects funded by the U.S. Department of Health and Human Services, including the National Institutes of Health.

The proposed changes, published on Oct. 6, include a new formal process that institutions would follow in reviewing allegations, a 30-day deadline for institutions to assess allegations, and provisions that make it harder to quickly dismiss cases that institutions believe to be “honest errors.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： New documents shed light on MD Anderson Cancer Institute feud

WSS

CDC overhauls leadership of center that led response to Covid

Genentech weighs delaying cancer therapy after drug pricing law

Large hospital system sues Multiplan for low

O'Shea Sibley was killed after expressing queer joy by voguing, activists say

NIH study of ME/CFS points to clear biological hallmarks

The perfect storm of weather conditions that led to the devastating wildfires in Maui

leisure time

comprehensive

hotspot

Activists slam private health insurers over coverage restrictions

White House drug shortages task force keeps mum with Congress

United colonoscopy coverage change 'may cost lives,' doctors say

After John Oliver segment, STAT readers share their opioid

BioMarin wins approval for gene therapy to treat hemophilia A

Alabama hospital puts IVF treatments on hold

Jerome Adams on the need for new antivirals for Covid

O'Shea Sibley was killed after expressing queer joy by voguing, activists say

Hepatitis C has a cure — but many Americans still lack access to it

Presidential candidate assassinated in Ecuador, 1 suspect dead and 6 arrested

focus

An innovative path out of biotech’s “valley of death”

Where are patients getting their prescriptions for GLP

An innovative path out of biotech’s “valley of death”

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn

The history of OxyContin, told through Purdue Pharma documents

Wikipedia

hotspot

explore

leisure time